These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 16634747
1. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. James PD, Paterson AD, Notley C, Cameron C, Hegadorn C, Tinlin S, Brown C, O'Brien L, Leggo J, Lillicrap D, ASSOCIATION OF HEMOPHILIA CLINIC DIRECTORS OF CANADA. J Thromb Haemost; 2006 Apr; 4(4):783-92. PubMed ID: 16634747 [Abstract] [Full Text] [Related]
5. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Casaña P, Martínez F, Haya S, Espinós C, Aznar JA. Br J Haematol; 2001 Dec; 115(3):692-700. PubMed ID: 11736956 [Abstract] [Full Text] [Related]
7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Acta Haematol; 2009 Dec; 121(2-3):128-38. PubMed ID: 19506359 [Abstract] [Full Text] [Related]
8. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort. Borràs N, Garcia-Martínez I, Batlle J, Pérez-Rodríguez A, Parra R, Altisent C, López-Fernández MF, Costa Pinto J, Batlle-López F, Cid AR, Bonanad S, Cabrera N, Moret A, Mingot-Castellano ME, Navarro N, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández-Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés-Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Del Mar Nieto M, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Corrales I, Vidal F. Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566 [Abstract] [Full Text] [Related]
9. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). Tosetto A, Rodeghiero F, Castaman G, Bernardi M, Bertoncello K, Goodeve A, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I. J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405 [Abstract] [Full Text] [Related]
19. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P, UK Haemophilia Centre Doctors' Organisation. Thromb Haemost; 2006 Nov 15; 96(5):630-41. PubMed ID: 17080221 [Abstract] [Full Text] [Related]
20. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease. Sanders YV, Groeneveld D, Meijer K, Fijnvandraat K, Cnossen MH, van der Bom JG, Coppens M, de Meris J, Laros-van Gorkom BA, Mauser-Bunschoten EP, Leebeek FW, Eikenboom J, WiN study group. Blood; 2015 May 07; 125(19):3006-13. PubMed ID: 25673639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]